Publication details

The EHA Research Roadmap: Malignant Lymphoid Diseases

Authors

DREYLING Martin ANDRE Marc GOKBUGET Nicola TILLY Herve JERKEMAN Mats GRIBBEN John FERRERI Andres MOREL Pierre STILGENBAUER Stephan FOX Christopher JOSE Maria Ribera ZWEEGMAN Sonja AURER Igor BODOR Csaba BURKHARDT Birgit BUSKE Christian MARIA Dollores Caballero CAMPO Elias CHAPUY Bjoern DAVIES Andrew LAURENCE de Leval DOORDUIJN Jeanette FEDERICO Massimo GAULARD Philippe GAY Francesca GHIA Paolo GRONBAEK Kirsten GOLDSCHMIDT Hartmut KERSTEN Marie-Jose KIESEWETTER Barbara LANDMAN-PARKER Judith STEVEN Le Gouill LENZ Georg LEPPA Sirpa LOPEZ-GUILLERMO Armando MACINTYRE Elizabeth MANTEGA Maria Victoria Mateos MOREAU Philippe MORENO Carol NADEL Bertrand OKOSUN Jessica OWEN Roger POSPÍŠILOVÁ Šárka POTT Christiane ROBAK Tadeusz SPINA Michelle STAMATOPOULOS Kostas STARY Jan TARTE Karin TEDESCHI Allessandra THIEBLEMONT Catherine TRAPPE Ralf Ulrich TRUMPER Lorenz H SALLES Gilles

Year of publication 2022
Type Article in Periodical
Magazine / Source HemaSphere
MU Faculty or unit

Faculty of Medicine

Citation
Web https://journals.lww.com/hemasphere/Fulltext/2022/06000/The_EHA_Research_Roadmap__Malignant_Lymphoid.10.aspx
Doi http://dx.doi.org/10.1097/HS9.0000000000000726
Keywords Malignant Lymphoid Diseases; EHA Research Roadmap
Description In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research aiming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.

You are running an old browser version. We recommend updating your browser to its latest version.

More info